Recent Updates
Recently added Catalysts
CHRS

Coherus BioSciences Management to Present at H.C. Wainwright 24th Annual Global Investment Conference

Key Takeaway: REDWOOD CITY, Calif., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that senior management will participate at the H.C. Wainwright 24th Annual Global Investment Conference on Wednesday, September 14 at 10:00 am ET. An aud
Price reaction · baseline $10.58 (2022-09-09 close) · clean, no other CHRS news in the window
day 0 close · peak
-0.7%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+136%
120-day peak, hindsight
Typical move
6.6%
average across 12 past catalysts
Cash runway
~5 mo
High dilution risk
Lead asset
CHS-0214
Phase 3 · Rheumatoid Arthritis

Full Press Release Details

REDWOOD CITY, Calif., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that senior management will participate at the H.C. Wainwright 24th Annual Global Investment Conference on Wednesday, September 14 at 10:00 am ET.
An audio webcast of the fireside chat will be available on the investor’s page of the Coherus website at https://investors.coherus.com/upcoming-events. Please access the website prior to the start of the presentation to ensure a timely connection to the webcast. The webcast will be archived on the Coherus website for 30 days.
Marek Ciszewski, J.D.
SVP, Investor Relations
Coherus BioSciences, Inc.
Last updated: Sep 12, 2022